Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00264511
Other study ID # 206/04
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date February 13, 2007
Est. completion date March 23, 2016

Study information

Verified date August 2023
Source Bayside Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study hypothesis :Hyperbaric Oxygen may prevent complications and improve outcomes in severe lower limb trauma. We propose to investigate this hypothesis by conducting an International multi centre randomised control trial of standard trauma/orthopaedic care with or without a concurrent course of hyperbaric oxygen treatments.


Description:

A randomised controlled trial was undertaken on using hyperbaric oxygen in addition to standard orthopaedic trauma care in severe lower leg injury, defined as an open tibial fracture with severe soft tissue injury. The control arm subjects received standard hospital trauma care whilst the intervention group received standard trauma care with the addition of hyperbaric oxygen therapy with the aim of providing 12 HBOT sessions over the first 9 days of hospital care. The primary outcome measure was the incidence of wound necrosis AND/OR wound infection as assessed at Day 14, with secondary outcomes of wound closure, wound complications, infections and delayed bone union at 12 months plus quality of life and functional questionnaire outcomes at 12 months and 2 years. The detailed study protocol was published in in June 2015 and the results were published in September 2022. Both publications are Open Access (See References section for publication details)


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date March 23, 2016
Est. primary completion date August 18, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Acute fracture of the tibia with significant soft tissue injury of Gustilo Grade 3 - Enrolment within 48 hours of injury with expectation of commencement of HBO therapy within 48 hours of injury - Valid consent Exclusion Criteria: - Significant head injury - Injuries incompatible with HBO - resuscitation requirements incompatible with HBO - follow up not possible - hyperbaric contra indications

Study Design


Intervention

Other:
Hyperbaric Oxygen Treatment
Subjects in the HBO treatment group will receive a course of hyperbaric oxygen therapy (HBO) in addition to normal trauma and general care. A total of 12 HBO sessions will be delivered over approximately 8 days. HBO treatment will be provided at 2.4 atmospheres absolute (ATA) pressure for approximately 90 minutes of oxygen therapy. Treatments should be twice daily for the first three days. Minor variability will be allowed with respect to timing and profile of each session.

Locations

Country Name City State
Australia Royal Hobart Hospital Hobart Tasmania
Australia The Alfred Melbourne Victoria
Austria Universitatsklinikum Graz Graz
Chile Hospital del Trabajador Santiago
Czechia City Hospital of Ostrava Ostrava
India Indraprastha Apollo Hospital New Delhi Sarita Vihar
Italy Policlinico Umberto 1, University of Rome Rome
Portugal Hospital Pedro Hispano Senhora da Hora Matosinhos
Sweden Karolinska Hospital Stockholm
United States John Muir Clinical Research Center Concord California

Sponsors (3)

Lead Sponsor Collaborator
Bayside Health Monash University, National Health and Medical Research Council, Australia

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Chile,  Czechia,  India,  Italy,  Portugal,  Sweden, 

References & Publications (4)

Bouachour G, Cronier P, Gouello JP, Toulemonde JL, Talha A, Alquier P. Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. J Trauma. 1996 Aug;41(2):333-9. doi: 10.1097/00005373-199608000-00023. — View Citation

Garcia-Covarrubias L, McSwain NE Jr, Van Meter K, Bell RM. Adjuvant hyperbaric oxygen therapy in the management of crush injury and traumatic ischemia: an evidence-based approach. Am Surg. 2005 Feb;71(2):144-51. — View Citation

Millar IL, Lind FG, Jansson KA, Hajek M, Smart DR, Fernandes TD, McGinnes RA, Williamson OD, Miller RK, Martin CA, Gabbe BJ, Myles PS, Cameron PA; HOLLT investigator group. Hyperbaric Oxygen for Lower Limb Trauma (HOLLT): an international multi-centre randomised clinical trial. Diving Hyperb Med. 2022 Sep 30;52(3):164-174. doi: 10.28920/dhm52.3.164-174. — View Citation

Millar IL, McGinnes RA, Williamson O, Lind F, Jansson KA, Hajek M, Smart D, Fernandes T, Miller R, Myles P, Cameron P. Hyperbaric Oxygen in Lower Limb Trauma (HOLLT); protocol for a randomised controlled trial. BMJ Open. 2015 Jun 11;5(6):e008381. doi: 10.1136/bmjopen-2015-008381. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Acute phase complication rate The incidence of acute complications after injury. A composite measure defined as the occurrence within two weeks of trauma of one or both of: significant soft tissue necrosis developing after the initial surgery or significant wound infection. up to 14 days post trauma
Secondary Amputation rate operative procedure records of a limb amputation related to the trauma under study 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Late infection records of diagnosis of wound infection or osteomyelitis or implant infection at defined times 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Radiological union electronic image copies of radiographs recorded by treating hospitals 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Quality of life score Short Form 36 quality of life questionnaire (algorithm produces a score in the range of 0-100 with higher score better) 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Functional outcome score lower limb function component of Short Musculoskeletal Function Assessment ((each question is scored 1-5 with lower score better) 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Pain score Subjects self reported pain using a 0-10 visual analogue scale 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Delayed union of fracture Any diagnosis of delayed union or non union or performance or scheduling of bone graft for union problems 12 months post trauma
Secondary Wound persistence A record of whether any injury related wound remains open at review. Excludes new surgical wounds. 3, 6, 9, 12, 18 and 24 months post trauma
Secondary Problem Wounds Blinded evaluation of whether post traumatic wounds met the criteria for "Problem Wounds" as a result of requiring readmission to hospital, prolonged wound care, additional surgery or antibiotics that complicated or deteriorated patient recovery 12 months post trauma
See also
  Status Clinical Trial Phase
Terminated NCT01927575 - Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury N/A
Completed NCT01017094 - Pin Site Infection Prevention for Open Tibial Fracture Phase 3
Completed NCT00038129 - SPRINT - Randomized Trial of Tibial Fracture Fixation N/A
Recruiting NCT01795287 - Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture N/A
Terminated NCT01300520 - The Development of a Surgical Localizing Aid Medical Device N/A
Active, not recruiting NCT05012449 - Transitional Ankle Fracture Management Using a New Joystick Technique N/A
Recruiting NCT04432389 - Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture Phase 2
Suspended NCT00365573 - Doppler Ultrasonography Evaluation of Tibial Fracture Site Vascularity Phase 2
Completed NCT02820363 - Study Evaluating CERAMENTâ„¢|G in Open Diaphyseal Tibial Fractures N/A
Completed NCT04028908 - Remodelling After Trampoline Fracture in Children
Completed NCT02140528 - Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures Phase 2
Active, not recruiting NCT03598530 - Fracture-Related Outcome Study for Operatively Treated Tibia Shaft Fractures
Not yet recruiting NCT01955577 - Vitamin D Supplement for Patients With Tibial Fracture Phase 1
Completed NCT00250302 - Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures Phase 1/Phase 2
Unknown status NCT02035917 - Comparison of Tibial Plateau Fractures Outcomes Treated With Non-locking and Locking Plate N/A

External Links